《大行報告》摩通下調新華保險(01336.HK)目標價至13元 評級「減持」
摩通發表報告,新華保險(01336.HK)去年業績表現疲軟,純利為149億元人民幣(下同),低過市場預期的156億元;新業務價值為59億元,低過該行預期的69億元;派股息1.44元,同樣低過市場預期的1.47元。該行將其目標價由15元下調至13元,維持「減持」評級。
報告認為,該股股價在過去12個月中表現跑輸大市,主要是由於市場對其投資賬面的擔憂。在今年第二季,該行認為有三點關於風險回報需要注意,包括在不太有利的宏觀環境下的投資息差前景;在短期儲蓄保單到期後現金流出情況下的新壽險銷售;以及C-ROSS II下的資產負債表能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.